You probably remember the best interaction you've ever had with a company, and the worst one too. But what makes one customer journey feel effortless, personal and relevant, while another feels slow, ...
How-To Geek on MSN
This tool lets you make magical code changes—without AI
If you thought grep was powerful, wait until you get a hold of ast-grep, which takes it to a whole new level.
Young and the Invested on MSN
Ghost in the cart: Top shrinkflation offenders quietly shaving your savings one ounce at a time
This article looks at the biggest offenders in the shrinkflation game.
Google ADK for Java 1.0 Introduces New App and Plugin Architecture, External Tools Support, and More
Google's Agent Development Kit for Java reached 1.0, introducing integrations with new external tools, a new app and plugin ...
LOWERING DRUG COSTS — Bipartisan lawmakers have revived efforts to require Medicare to cover generic drugs — and at least two biosimilars — with patients paying lower costs than for brand-name drugs, ...
The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...
Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...
Multiple dapagliflozin generic approvals are expected to intensify near-term market competition, requiring manufacturers to coordinate production readiness, launch timing, and labeling compliance ...
The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...
March 31 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Lizzy Lawrence leads STAT’s ...
Stop writing vague AI prompts. Discover the 20-minute workflow to structure, debug, and refine your Claude prompts for better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results